Share Price and Basic Stock Data
Last Updated: December 13, 2025, 12:53 am
| PEG Ratio | -1.24 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Finolex Industries Ltd operates in the plastics sector, specifically focusing on pipes and fittings. The company has demonstrated a resilient revenue trajectory, with reported sales of ₹4,397 Cr for FY 2023. However, this reflects a decline from ₹4,647 Cr in FY 2022, highlighting some challenges in maintaining growth. The trailing twelve months (TTM) revenue stands at ₹4,045 Cr, suggesting a slight recovery from the previous year but still indicating a need for strategic adjustments. Notably, the quarterly sales figures have shown fluctuations, with the most recent quarter reporting ₹1,235 Cr, which is a promising uptick from ₹1,020 Cr in December 2023. This variability may signal the impact of seasonal demand and market conditions, which investors must consider when evaluating the company’s sales stability.
Profitability and Efficiency Metrics
In terms of profitability, Finolex Industries has faced some headwinds. The operating profit margin (OPM) stood at a modest 9% in the most recent fiscal year, down from 22% in FY 2022. This decline reflects rising costs and competitive pressures, which have squeezed margins significantly. The company reported a net profit of ₹370 Cr, translating to an earnings per share (EPS) of ₹5.95. While the interest coverage ratio (ICR) remains strong at 24.37x, indicating that the company comfortably meets its interest obligations, the return on equity (ROE) of 6.76% appears lackluster compared to industry peers. Investors should be cautious of these profitability metrics, as they may affect future growth and dividend payouts.
Balance Sheet Strength and Financial Ratios
The balance sheet of Finolex Industries showcases a conservative financial structure, characterized by minimal borrowings of just ₹21 Cr, which is a fraction of the overall liabilities of ₹6,609 Cr. This low debt level positions the company comfortably to weather economic fluctuations. With reserves amounting to ₹5,666 Cr, the company has a solid cushion for potential investments or dividend distributions. However, the price-to-book value (P/BV) ratio of 1.83x suggests that the stock might be trading at a premium compared to its intrinsic value, which could indicate overvaluation concerns. Additionally, the current ratio of 3.56x implies robust liquidity, ensuring that the company can meet its short-term obligations easily.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Finolex Industries reflects a stable ownership structure, with promoters holding 52.47% of the shares. Institutional investors, including foreign institutional investors (FIIs) and domestic institutional investors (DIIs), account for approximately 18% of the total shareholding, indicating a healthy level of institutional interest. The public holds about 29.13% of the shares, which suggests a reasonably diversified investor base. However, the decline in the number of shareholders from 2,48,095 in December 2022 to 2,45,505 indicates a slight reduction in retail participation, potentially signaling waning investor confidence. This aspect is crucial as it could influence the stock’s liquidity and price stability.
Outlook, Risks, and Final Insight
The outlook for Finolex Industries appears mixed. On one hand, the company has a strong balance sheet and low debt levels, which provide a solid foundation for future growth. On the other hand, the declining profitability margins and fluctuating revenue trends raise concerns about its operational efficiency. Investors should be mindful of the risks posed by market competition and raw material price volatility, which could further pressure margins. Additionally, the company’s reliance on the cyclical nature of the construction and infrastructure sectors could expose it to demand fluctuations. Overall, while Finolex Industries has strengths that may appeal to conservative investors, the current challenges necessitate a cautious approach, weighing potential rewards against inherent risks in the evolving market landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Finolex Industries Ltd | 10,276 Cr. | 166 | 270/144 | 23.5 | 93.3 | 1.21 % | 8.77 % | 6.76 % | 2.00 |
| Industry Average | 10,276.00 Cr | 166.00 | 23.50 | 93.30 | 1.21% | 8.77% | 6.76% | 2.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,190 | 941 | 1,125 | 1,141 | 1,179 | 883 | 1,020 | 1,235 | 1,140 | 828 | 1,001 | 1,172 | 1,043 |
| Expenses | 1,064 | 1,084 | 1,033 | 924 | 1,027 | 780 | 900 | 1,026 | 934 | 818 | 918 | 1,001 | 950 |
| Operating Profit | 126 | -143 | 92 | 217 | 152 | 103 | 120 | 209 | 207 | 11 | 83 | 171 | 94 |
| OPM % | 11% | -15% | 8% | 19% | 13% | 12% | 12% | 17% | 18% | 1% | 8% | 15% | 9% |
| Other Income | 25 | 39 | 28 | 29 | 40 | 63 | 35 | 44 | 472 | 84 | 48 | 65 | 65 |
| Interest | 11 | 4 | 5 | 6 | 9 | 12 | 8 | 7 | 7 | 7 | 10 | 6 | 6 |
| Depreciation | 21 | 22 | 22 | 24 | 34 | 27 | 28 | 27 | 26 | 26 | 27 | 27 | 27 |
| Profit before tax | 118 | -129 | 92 | 216 | 149 | 126 | 120 | 219 | 646 | 62 | 95 | 203 | 126 |
| Tax % | 15% | -27% | 22% | 27% | 26% | 25% | 26% | 26% | 22% | 16% | 25% | 26% | 23% |
| Net Profit | 100 | -94 | 72 | 158 | 111 | 94 | 89 | 161 | 505 | 51 | 71 | 150 | 97 |
| EPS in Rs | 1.61 | -1.51 | 1.16 | 2.55 | 1.79 | 1.51 | 1.44 | 2.60 | 8.14 | 0.83 | 1.14 | 2.42 | 1.56 |
Last Updated: August 20, 2025, 10:45 am
Below is a detailed analysis of the quarterly data for Finolex Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 1,043.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,172.00 Cr. (Mar 2025) to 1,043.00 Cr., marking a decrease of 129.00 Cr..
- For Expenses, as of Jun 2025, the value is 950.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,001.00 Cr. (Mar 2025) to 950.00 Cr., marking a decrease of 51.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 94.00 Cr.. The value appears to be declining and may need further review. It has decreased from 171.00 Cr. (Mar 2025) to 94.00 Cr., marking a decrease of 77.00 Cr..
- For OPM %, as of Jun 2025, the value is 9.00%. The value appears to be declining and may need further review. It has decreased from 15.00% (Mar 2025) to 9.00%, marking a decrease of 6.00%.
- For Other Income, as of Jun 2025, the value is 65.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 65.00 Cr..
- For Interest, as of Jun 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
- For Depreciation, as of Jun 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 27.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 126.00 Cr.. The value appears to be declining and may need further review. It has decreased from 203.00 Cr. (Mar 2025) to 126.00 Cr., marking a decrease of 77.00 Cr..
- For Tax %, as of Jun 2025, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Mar 2025) to 23.00%, marking a decrease of 3.00%.
- For Net Profit, as of Jun 2025, the value is 97.00 Cr.. The value appears to be declining and may need further review. It has decreased from 150.00 Cr. (Mar 2025) to 97.00 Cr., marking a decrease of 53.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.56. The value appears to be declining and may need further review. It has decreased from 2.42 (Mar 2025) to 1.56, marking a decrease of 0.86.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:21 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,453 | 2,476 | 2,482 | 2,602 | 2,738 | 3,091 | 2,985 | 3,462 | 4,647 | 4,397 | 4,317 | 4,142 | 4,045 |
| Expenses | 2,056 | 2,264 | 2,075 | 2,039 | 2,253 | 2,487 | 2,536 | 2,472 | 3,623 | 4,105 | 3,732 | 3,666 | 3,686 |
| Operating Profit | 397 | 212 | 407 | 563 | 484 | 604 | 448 | 990 | 1,025 | 293 | 585 | 476 | 359 |
| OPM % | 16% | 9% | 16% | 22% | 18% | 20% | 15% | 29% | 22% | 7% | 14% | 12% | 9% |
| Other Income | -27 | -2 | 62 | 24 | 25 | 14 | 30 | 72 | 458 | 121 | 181 | 665 | 262 |
| Interest | 66 | 70 | 45 | 15 | 10 | 12 | 11 | 7 | 14 | 27 | 36 | 30 | 28 |
| Depreciation | 62 | 59 | 51 | 55 | 61 | 70 | 74 | 78 | 83 | 89 | 116 | 107 | 107 |
| Profit before tax | 242 | 81 | 373 | 517 | 439 | 536 | 393 | 977 | 1,385 | 297 | 613 | 1,005 | 485 |
| Tax % | 30% | 41% | 32% | 32% | 32% | 35% | 18% | 25% | 24% | 20% | 26% | 23% | |
| Net Profit | 170 | 48 | 254 | 352 | 299 | 350 | 324 | 728 | 1,053 | 237 | 455 | 778 | 370 |
| EPS in Rs | 2.74 | 0.77 | 4.10 | 5.68 | 4.81 | 5.64 | 5.22 | 11.73 | 16.98 | 3.81 | 7.34 | 12.54 | 5.95 |
| Dividend Payout % | 51% | 52% | 49% | 41% | 42% | 35% | 38% | 34% | 24% | 39% | 34% | 29% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -71.76% | 429.17% | 38.58% | -15.06% | 17.06% | -7.43% | 124.69% | 44.64% | -77.49% | 91.98% | 70.99% |
| Change in YoY Net Profit Growth (%) | 0.00% | 500.93% | -390.58% | -53.64% | 32.11% | -24.49% | 132.12% | -80.05% | -122.14% | 169.48% | -20.99% |
Finolex Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 7% |
| 3 Years: | -4% |
| TTM: | -5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 4% |
| 3 Years: | -20% |
| TTM: | -29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 16% |
| 3 Years: | 12% |
| 1 Year: | -29% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 12% |
| 3 Years: | 7% |
| Last Year: | 7% |
Last Updated: September 5, 2025, 4:10 am
Balance Sheet
Last Updated: December 4, 2025, 1:15 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 |
| Reserves | 666 | 663 | 1,446 | 2,167 | 2,640 | 2,404 | 1,806 | 2,949 | 3,740 | 4,701 | 5,414 | 5,855 | 5,666 |
| Borrowings | 713 | 637 | 212 | 94 | 101 | 90 | 283 | 204 | 278 | 541 | 394 | 237 | 21 |
| Other Liabilities | 433 | 435 | 567 | 570 | 589 | 655 | 603 | 930 | 1,119 | 817 | 996 | 1,008 | 798 |
| Total Liabilities | 1,936 | 1,859 | 2,349 | 2,955 | 3,455 | 3,273 | 2,815 | 4,207 | 5,261 | 6,182 | 6,928 | 7,223 | 6,609 |
| Fixed Assets | 905 | 868 | 850 | 855 | 884 | 951 | 1,017 | 1,002 | 993 | 1,055 | 1,055 | 1,008 | 1,015 |
| CWIP | 32 | 10 | 7 | 22 | 90 | 90 | 7 | 8 | 9 | 44 | 19 | 73 | 41 |
| Investments | 221 | 180 | 817 | 1,222 | 1,555 | 1,303 | 580 | 1,592 | 2,633 | 3,850 | 4,456 | 4,751 | 4,239 |
| Other Assets | 777 | 801 | 675 | 856 | 925 | 929 | 1,211 | 1,604 | 1,625 | 1,234 | 1,398 | 1,391 | 1,314 |
| Total Assets | 1,936 | 1,859 | 2,349 | 2,955 | 3,455 | 3,273 | 2,815 | 4,207 | 5,261 | 6,182 | 6,928 | 7,223 | 6,609 |
Below is a detailed analysis of the balance sheet data for Finolex Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 124.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 124.00 Cr..
- For Reserves, as of Sep 2025, the value is 5,666.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5,855.00 Cr. (Mar 2025) to 5,666.00 Cr., marking a decrease of 189.00 Cr..
- For Borrowings, as of Sep 2025, the value is 21.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 237.00 Cr. (Mar 2025) to 21.00 Cr., marking a decrease of 216.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 798.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,008.00 Cr. (Mar 2025) to 798.00 Cr., marking a decrease of 210.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 6,609.00 Cr.. The value appears to be improving (decreasing). It has decreased from 7,223.00 Cr. (Mar 2025) to 6,609.00 Cr., marking a decrease of 614.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,015.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,008.00 Cr. (Mar 2025) to 1,015.00 Cr., marking an increase of 7.00 Cr..
- For CWIP, as of Sep 2025, the value is 41.00 Cr.. The value appears to be declining and may need further review. It has decreased from 73.00 Cr. (Mar 2025) to 41.00 Cr., marking a decrease of 32.00 Cr..
- For Investments, as of Sep 2025, the value is 4,239.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,751.00 Cr. (Mar 2025) to 4,239.00 Cr., marking a decrease of 512.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,314.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,391.00 Cr. (Mar 2025) to 1,314.00 Cr., marking a decrease of 77.00 Cr..
- For Total Assets, as of Sep 2025, the value is 6,609.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7,223.00 Cr. (Mar 2025) to 6,609.00 Cr., marking a decrease of 614.00 Cr..
Notably, the Reserves (5,666.00 Cr.) exceed the Borrowings (21.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -316.00 | -425.00 | 195.00 | 469.00 | 383.00 | 514.00 | 165.00 | 786.00 | -277.00 | -248.00 | 191.00 | 239.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 6 | 7 | 3 | 7 | 6 | 9 | 9 | 16 | 26 | 25 | 39 | 33 |
| Inventory Days | 112 | 113 | 100 | 128 | 128 | 120 | 164 | 176 | 132 | 81 | 99 | 108 |
| Days Payable | 25 | 40 | 55 | 52 | 52 | 55 | 44 | 84 | 60 | 35 | 39 | 61 |
| Cash Conversion Cycle | 93 | 80 | 48 | 83 | 81 | 74 | 129 | 108 | 98 | 71 | 98 | 80 |
| Working Capital Days | -14 | -6 | 0 | 28 | 32 | 33 | 39 | 22 | 17 | -6 | 13 | 20 |
| ROCE % | 23% | 11% | 24% | 25% | 17% | 21% | 16% | 36% | 27% | 6% | 10% | 9% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Small Cap Fund | 34,595,699 | 1.76 | 650.43 | 34,595,699 | 2025-04-22 14:12:25 | 0% |
| Franklin India Small Cap Fund | 7,057,734 | 0.96 | 132.69 | N/A | N/A | N/A |
| HSBC Small Cap Fund | 5,984,579 | 0.68 | 112.52 | N/A | N/A | N/A |
| ICICI Prudential Smallcap Fund | 3,200,000 | 0.7 | 60.16 | N/A | N/A | N/A |
| SBI Conservative Hybrid Fund | 2,476,176 | 0.47 | 46.56 | 2,476,176 | 2025-04-22 15:56:58 | 0% |
| HDFC Retirement Savings Fund - Equity | 1,650,000 | 0.45 | 31.02 | N/A | N/A | N/A |
| Bandhan Multi Cap Fund | 1,299,000 | 0.86 | 24.42 | N/A | N/A | N/A |
| Templeton India Value Fund | 1,100,000 | 0.92 | 20.68 | N/A | N/A | N/A |
| ICICI Prudential Childrens Fund | 1,000,000 | 1.33 | 18.8 | N/A | N/A | N/A |
| HDFC Equity Savings Fund | 600,000 | 0.19 | 11.28 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 10.00 |
| Basic EPS (Rs.) | 12.94 | 7.66 | 4.04 | 16.94 | 11.89 |
| Diluted EPS (Rs.) | 12.94 | 7.66 | 4.04 | 16.94 | 11.89 |
| Cash EPS (Rs.) | 14.01 | 8.92 | 5.10 | 18.31 | 64.41 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 98.60 | 91.12 | 79.29 | 63.30 | 252.94 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 98.60 | 91.12 | 79.29 | 63.30 | 252.94 |
| Revenue From Operations / Share (Rs.) | 66.98 | 69.82 | 71.11 | 74.90 | 279.03 |
| PBDIT / Share (Rs.) | 11.68 | 12.37 | 6.69 | 17.82 | 85.48 |
| PBIT / Share (Rs.) | 9.96 | 10.49 | 5.24 | 16.48 | 79.22 |
| PBT / Share (Rs.) | 16.22 | 9.90 | 4.80 | 22.31 | 78.64 |
| Net Profit / Share (Rs.) | 12.29 | 7.04 | 3.66 | 16.97 | 58.15 |
| NP After MI And SOA / Share (Rs.) | 12.94 | 7.66 | 4.05 | 16.94 | 59.45 |
| PBDIT Margin (%) | 17.44 | 17.71 | 9.40 | 23.79 | 30.63 |
| PBIT Margin (%) | 14.86 | 15.02 | 7.37 | 22.00 | 28.39 |
| PBT Margin (%) | 24.21 | 14.18 | 6.75 | 29.79 | 28.18 |
| Net Profit Margin (%) | 18.34 | 10.08 | 5.14 | 22.65 | 20.83 |
| NP After MI And SOA Margin (%) | 19.31 | 10.96 | 5.70 | 22.62 | 21.30 |
| Return on Networth / Equity (%) | 13.12 | 8.40 | 5.11 | 26.76 | 23.50 |
| Return on Capital Employeed (%) | 9.61 | 10.89 | 6.29 | 24.66 | 29.27 |
| Return On Assets (%) | 10.83 | 6.71 | 3.98 | 19.66 | 17.18 |
| Total Debt / Equity (X) | 0.03 | 0.06 | 0.10 | 0.07 | 0.06 |
| Asset Turnover Ratio (%) | 0.57 | 0.64 | 0.75 | 0.97 | 0.97 |
| Current Ratio (X) | 3.56 | 2.90 | 2.55 | 2.54 | 2.12 |
| Quick Ratio (X) | 2.75 | 2.24 | 1.95 | 1.69 | 1.14 |
| Inventory Turnover Ratio (X) | 5.48 | 3.92 | 3.44 | 2.90 | 2.18 |
| Dividend Payout Ratio (NP) (%) | 19.32 | 19.58 | 98.99 | 23.60 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 17.05 | 15.73 | 73.01 | 21.87 | 0.00 |
| Earning Retention Ratio (%) | 80.68 | 80.42 | 1.01 | 76.40 | 0.00 |
| Cash Earning Retention Ratio (%) | 82.95 | 84.27 | 26.99 | 78.13 | 0.00 |
| Interest Coverage Ratio (X) | 24.37 | 20.98 | 15.18 | 78.49 | 145.92 |
| Interest Coverage Ratio (Post Tax) (X) | 12.57 | 12.94 | 9.32 | 49.03 | 100.26 |
| Enterprise Value (Cr.) | 11222.93 | 15601.90 | 11024.14 | 9802.33 | 7772.76 |
| EV / Net Operating Revenue (X) | 2.71 | 3.61 | 2.51 | 2.11 | 2.24 |
| EV / EBITDA (X) | 15.53 | 20.40 | 26.66 | 8.86 | 7.33 |
| MarketCap / Net Operating Revenue (X) | 2.69 | 3.53 | 2.40 | 2.07 | 2.28 |
| Retention Ratios (%) | 80.67 | 80.41 | 1.00 | 76.39 | 0.00 |
| Price / BV (X) | 1.83 | 2.71 | 2.15 | 2.45 | 2.52 |
| Price / Net Operating Revenue (X) | 2.69 | 3.53 | 2.40 | 2.07 | 2.28 |
| EarningsYield | 0.07 | 0.03 | 0.02 | 0.10 | 0.09 |
After reviewing the key financial ratios for Finolex Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.94. This value is within the healthy range. It has increased from 7.66 (Mar 24) to 12.94, marking an increase of 5.28.
- For Diluted EPS (Rs.), as of Mar 25, the value is 12.94. This value is within the healthy range. It has increased from 7.66 (Mar 24) to 12.94, marking an increase of 5.28.
- For Cash EPS (Rs.), as of Mar 25, the value is 14.01. This value is within the healthy range. It has increased from 8.92 (Mar 24) to 14.01, marking an increase of 5.09.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 98.60. It has increased from 91.12 (Mar 24) to 98.60, marking an increase of 7.48.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 98.60. It has increased from 91.12 (Mar 24) to 98.60, marking an increase of 7.48.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 66.98. It has decreased from 69.82 (Mar 24) to 66.98, marking a decrease of 2.84.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 11.68. This value is within the healthy range. It has decreased from 12.37 (Mar 24) to 11.68, marking a decrease of 0.69.
- For PBIT / Share (Rs.), as of Mar 25, the value is 9.96. This value is within the healthy range. It has decreased from 10.49 (Mar 24) to 9.96, marking a decrease of 0.53.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.22. This value is within the healthy range. It has increased from 9.90 (Mar 24) to 16.22, marking an increase of 6.32.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 12.29. This value is within the healthy range. It has increased from 7.04 (Mar 24) to 12.29, marking an increase of 5.25.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 12.94. This value is within the healthy range. It has increased from 7.66 (Mar 24) to 12.94, marking an increase of 5.28.
- For PBDIT Margin (%), as of Mar 25, the value is 17.44. This value is within the healthy range. It has decreased from 17.71 (Mar 24) to 17.44, marking a decrease of 0.27.
- For PBIT Margin (%), as of Mar 25, the value is 14.86. This value is within the healthy range. It has decreased from 15.02 (Mar 24) to 14.86, marking a decrease of 0.16.
- For PBT Margin (%), as of Mar 25, the value is 24.21. This value is within the healthy range. It has increased from 14.18 (Mar 24) to 24.21, marking an increase of 10.03.
- For Net Profit Margin (%), as of Mar 25, the value is 18.34. This value exceeds the healthy maximum of 10. It has increased from 10.08 (Mar 24) to 18.34, marking an increase of 8.26.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 19.31. This value is within the healthy range. It has increased from 10.96 (Mar 24) to 19.31, marking an increase of 8.35.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.12. This value is below the healthy minimum of 15. It has increased from 8.40 (Mar 24) to 13.12, marking an increase of 4.72.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.61. This value is below the healthy minimum of 10. It has decreased from 10.89 (Mar 24) to 9.61, marking a decrease of 1.28.
- For Return On Assets (%), as of Mar 25, the value is 10.83. This value is within the healthy range. It has increased from 6.71 (Mar 24) to 10.83, marking an increase of 4.12.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.03. This value is within the healthy range. It has decreased from 0.06 (Mar 24) to 0.03, marking a decrease of 0.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.57. It has decreased from 0.64 (Mar 24) to 0.57, marking a decrease of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 3.56. This value exceeds the healthy maximum of 3. It has increased from 2.90 (Mar 24) to 3.56, marking an increase of 0.66.
- For Quick Ratio (X), as of Mar 25, the value is 2.75. This value exceeds the healthy maximum of 2. It has increased from 2.24 (Mar 24) to 2.75, marking an increase of 0.51.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.48. This value is within the healthy range. It has increased from 3.92 (Mar 24) to 5.48, marking an increase of 1.56.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 19.32. This value is below the healthy minimum of 20. It has decreased from 19.58 (Mar 24) to 19.32, marking a decrease of 0.26.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 17.05. This value is below the healthy minimum of 20. It has increased from 15.73 (Mar 24) to 17.05, marking an increase of 1.32.
- For Earning Retention Ratio (%), as of Mar 25, the value is 80.68. This value exceeds the healthy maximum of 70. It has increased from 80.42 (Mar 24) to 80.68, marking an increase of 0.26.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 82.95. This value exceeds the healthy maximum of 70. It has decreased from 84.27 (Mar 24) to 82.95, marking a decrease of 1.32.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 24.37. This value is within the healthy range. It has increased from 20.98 (Mar 24) to 24.37, marking an increase of 3.39.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 12.57. This value is within the healthy range. It has decreased from 12.94 (Mar 24) to 12.57, marking a decrease of 0.37.
- For Enterprise Value (Cr.), as of Mar 25, the value is 11,222.93. It has decreased from 15,601.90 (Mar 24) to 11,222.93, marking a decrease of 4,378.97.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.71. This value is within the healthy range. It has decreased from 3.61 (Mar 24) to 2.71, marking a decrease of 0.90.
- For EV / EBITDA (X), as of Mar 25, the value is 15.53. This value exceeds the healthy maximum of 15. It has decreased from 20.40 (Mar 24) to 15.53, marking a decrease of 4.87.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.69. This value is within the healthy range. It has decreased from 3.53 (Mar 24) to 2.69, marking a decrease of 0.84.
- For Retention Ratios (%), as of Mar 25, the value is 80.67. This value exceeds the healthy maximum of 70. It has increased from 80.41 (Mar 24) to 80.67, marking an increase of 0.26.
- For Price / BV (X), as of Mar 25, the value is 1.83. This value is within the healthy range. It has decreased from 2.71 (Mar 24) to 1.83, marking a decrease of 0.88.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.69. This value is within the healthy range. It has decreased from 3.53 (Mar 24) to 2.69, marking a decrease of 0.84.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.07, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Finolex Industries Ltd:
- Net Profit Margin: 18.34%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.61% (Industry Average ROCE: 8.77%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.12% (Industry Average ROE: 6.76%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 12.57
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.75
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 23.5 (Industry average Stock P/E: 23.5)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.03
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 18.34%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plastics - Pipes & Fittings | Gat No. 399, Village Urse, Pune District Maharashtra 410506 | investors@finolexind.com www.finolexpipes.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Prakash P Chhabria | Executive Chairman |
| Mr. Saurabh S Dhanorkar | Managing Director |
| Mr. Saumya Chakrabarti | Director - Technical |
| Mrs. Ritu P Chhabria | Non Exe.Non Ind.Director |
| Mrs. Kanchan U Chitale | Independent Director |
| Mr. Debabrata Sarkar | Independent Director |
| Mr. Vijay Bhatt | Independent Director |
| Mr. Aditya Sapru | Independent Director |
| Mr. Munesh Khanna | Independent Director |
| Mr. Pradeep Udhas | Independent Director |
| Mr. Rajesh Rathi | Independent Director |
FAQ
What is the intrinsic value of Finolex Industries Ltd?
Finolex Industries Ltd's intrinsic value (as of 12 December 2025) is 120.01 which is 27.70% lower the current market price of 166.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 10,276 Cr. market cap, FY2025-2026 high/low of 270/144, reserves of ₹5,666 Cr, and liabilities of 6,609 Cr.
What is the Market Cap of Finolex Industries Ltd?
The Market Cap of Finolex Industries Ltd is 10,276 Cr..
What is the current Stock Price of Finolex Industries Ltd as on 12 December 2025?
The current stock price of Finolex Industries Ltd as on 12 December 2025 is 166.
What is the High / Low of Finolex Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Finolex Industries Ltd stocks is 270/144.
What is the Stock P/E of Finolex Industries Ltd?
The Stock P/E of Finolex Industries Ltd is 23.5.
What is the Book Value of Finolex Industries Ltd?
The Book Value of Finolex Industries Ltd is 93.3.
What is the Dividend Yield of Finolex Industries Ltd?
The Dividend Yield of Finolex Industries Ltd is 1.21 %.
What is the ROCE of Finolex Industries Ltd?
The ROCE of Finolex Industries Ltd is 8.77 %.
What is the ROE of Finolex Industries Ltd?
The ROE of Finolex Industries Ltd is 6.76 %.
What is the Face Value of Finolex Industries Ltd?
The Face Value of Finolex Industries Ltd is 2.00.